I'm concerned that a country like China that has a coordinated, focused, nationally funded IP strategy can exploit the fact that there's no standing requirement in inter partes review in PTAB to swamp it, with basically unlimited resources.
Coons highlights concerns about China's exploitation of U.S. patent review processes.
Share
More from Christopher Coons
I believe that allowing any companies in China to purchase these products presents a serious risk to our national security and economic leadership.
Since then, our confidence and our view, at least mine, and I think, having conversations with Senator Shaheen, have been disappointed.
Other voices in this conversation
